Cvs Health dividend calculator – CVS Health: 30 Years of Dividend Reliability and Positive Potential

☀️Trending News

CVS ($NYSE:CVS) Health is the nation’s largest health care services company, providing innovative solutions to help people on their path to better health. It has been a leader in the industry for over 30 years, consistently delivering reliable dividend payments to its shareholders. Throughout this time, CVS Health has not reduced its dividends and has only increased them year after year, making it an attractive option for investors. The commitment towards dividend reliability from CVS Health is a testament to the company’s financial stability and performance. Furthermore, the company’s performance is backed by a strong balance sheet and cash flow, allowing it to consistently reward shareholders with reliable dividends.

CVS Health offers investors great potential for growth. With its consistent dividend payments, expanding portfolio of products and services, and commitment to innovation, CVS Health is well positioned to continue to be a leader in the healthcare industry for years to come. For those looking for reliable dividend-paying stocks with positive potential, CVS Health is an attractive option.

Dividends – Cvs Health dividend calculator

CVS Health has proven itself to be a reliable dividend stock for the past 30 years. Over the last three years, CVS Health has issued an annual dividend per share of 2.37, 2.2 and 2.0 USD respectively. This shows a gradual and stable dividend return for investors over this period of time. Looking forward, dividend yields from 2021 to 2023 are expected to be 2.76%, 2.23% and 2.59%, with an average dividend yield of 2.53%.

This indicates that CVS Health is likely to continue providing steady and consistent dividend returns for investors in the future. If you are keen in investing in dividend stocks, CVS Health might be worth considering. With its long history of dividend reliability and positive potential, CVS Health could be a great addition to any investor’s portfolio.

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Cvs Health. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Cvs Health. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Cvs Health. More…

Key Ratios Snapshot

Some of the financial key ratios for Cvs Health are shown below. More…

Price History

CVS Health has provided reliable dividends for the past 30 years, and its stock has seen positive potential in recent months. On Monday, CVS Health stock opened at $69.4 and closed at $68.7, dropping 1.0% from its prior closing price of $69.4. It has been on a steady upward trajectory since mid-March of this year, slowly gaining in value. This trend shows that the company is doing well and investors are confident in its future performance. The long-term stability and reliability of CVS Health’s dividend shows that it is a safe investment for the long haul.

The company has been consistently profitable, and its dividends have been reliable and steady over the years. Investors can rely on the dividends as a steady source of returns, and the potential for further growth makes it an attractive option for investors looking to diversify their portfolios. Its stock has been steadily increasing in value since mid-March of this year, which is a promising sign that the company is doing well and investors are confident in its future performance. The long-term stability and reliability of its dividends provides investors with a safe option for their portfolio. Live Quote…

Analysis

GoodWhale recently conducted an analysis of CVS HEALTH’s wellbeing. Our Star Chart showed that CVS HEALTH is strong in dividend, growth, and medium in profitability while being weak in asset. We found that CVS HEALTH has a high health score of 8/10 with regard to its cashflows and debt, indicating that it is capable to pay off debt and fund future operations. We classified CVS HEALTH as ‘rhino’, a type of company we conclude that has achieved moderate revenue or earnings growth. This means that investors interested in these types of companies may find CVS HEALTH to be a profitable investment opportunity. More…

Peers

The competition between CVS Health Corp and its competitors is fierce. Each company is striving to be the top provider of healthcare services and products. CVS Health Corp is the largest provider of pharmacy services in the United States. Marpai Inc is a close second. Molina Healthcare Inc and Humana Inc are also major competitors in the healthcare industry.

– Marpai Inc ($NASDAQ:MRAI)

Marpai Inc is a publicly traded company with a market capitalization of 20.89 million as of 2022. The company has a return on equity of -64.66%. Marpai Inc is engaged in the business of developing and marketing products and services for the energy industry. The company’s products and services include oil and gas exploration, production, and development; oilfield services; and petrochemical refining.

– Molina Healthcare Inc ($NYSE:MOH)

Molina Healthcare Inc is a health care company that provides Medicaid-related solutions for low-income families and individuals. As of 2022, the company had a market capitalization of 20.52 billion dollars and a return on equity of 24.89%. The company’s main business is providing managed care services under the Medicaid and Medicare programs. In addition to this, the company also provides other health services such as behavioral health, long-term care, and pharmacy services.

– Humana Inc ($NYSE:HUM)

Humana Inc is a healthcare company that offers a wide range of health and wellness products and services. The company has a market cap of 63.3B as of 2022 and a return on equity of 17.4%. Humana’s products and services include medical and prescription drug coverage, dental and vision coverage, and wellness and fitness programs. The company also offers a variety of health and wellness products and services for individuals, families, and businesses.

Summary

CVS Health is a reliable long-term investment choice. The company has not reduced its dividend in thirty years, showing a consistent commitment to rewarding shareholders.

Additionally, CVS Health’s stock has a strong upside potential, with analysts predicting high returns over the long-term. The company’s strong financial position, attractive valuation and competitive advantages make it an attractive choice for investors looking for steady, long-term growth. Its healthcare portfolio provides investors with exposure to dynamic and growing sectors. CVS Health has also initiated several initiatives to enhance operational efficiency and provide cost saving opportunities. This combination of factors makes CVS Health an excellent choice for long-term investors.